|
| Title | Plant species | Isolate/fraction | Administration | Doses used | Duration of treatment |
|
Isolates | [25] A Polysaccharide Extract of Mulberry Leaf Ameliorates Hepatic Glucose Metabolism and Insulin Signaling in Rats with Type 2 Diabetes Induced by High Fat-Diet and Streptozotocin | Mulberry | Mulberry leaf polysaccharide | Gavage | 200 mg/kg | 6 days of treatment |
[26] Antidiabetic Activity of a Xanthone Compound, Mangiferin | Anemarrhena asphodeloides Bunge | Mangiferin | Orally | 30 mg/kg | ? |
[27] Anti-Diabetic Effect of a Novel N-Trisaccharide Isolated from Cucumis prophetarum on Streptozotocin-Nicotinamide Induced Type 2 Diabetic Rats | Cucumis prophetarum | N-Trisaccharide | Gavage | 50, 5 mg/kg | 28 days of treatment |
[28] Antidiabetic Effects of the Cimicifuga racemosa Extract Ze 450 In Vitro and In Vivo in ob/ob Mice | Cimicifuga racemosa | Ze 450 | Gavage | 10, 30, 90 mg/kg | 7 days of treatment |
[29] Borapetoside C from Tinospora crispa Improves Insulin Sensitivity in Diabetic Mice | Tinospora crispa | Borapetoside C | Orally | 5 mg/kg | 4 weeks of treatment |
[30] Dehydrotrametenolic Acid Induces Preadipocyte Differentiation and Sensitizes Animal Models of Noninsulin-Dependent Diabetes Mellitus to Insulin | Poria cocos Wolf | Dehydrotrametenolic acid | Gavage | 110 mg/kg | 14 days of treatment |
[31] Effects of Ingested Fruiting Bodies, Submerged Culture Biomass, and Acidic Polysaccharide Glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on Glycemic Responses in Normal and Diabetic Rats | Tremella mesenterica | Acidic polysaccharide glucuronoxylomannan (GXM) | Gavage | 1 g/kg | 15 days of treatment |
[32] Inhibition of Glycogen Synthase Kinase-3β by Falcarindiol Isolated from Japanese Parsley (Oenanthe javanica) | Oenanthe javanica | falcarindiol | Orally | 15 mg/kg | ? |
[33] Isolation and Antihyperglycemic Activity of Bakuchiol from Otholobium pubescens (Fabaceae), a Peruvian Medicinal Plant Used for the Treatment of Diabetes | Otholobium pubescens | Bakuchiol | Gavage | 1, 150, 250 mg/kg | 2 weeks of treatment |
[34] LBP-4a Improves Insulin Resistance via Translocation and Activation of GLUT4 in OLETF Rats | Lycium barbarum | Lycium barbarum polysaccharide (LBP-4a) | Orally | 10 mg/kg | 4 weeks of treatment |
[35] Meliacinolin: A Potent Α-Glucosidase and Α-Amylase Inhibitor Isolated from Azadirachta indica Leaves and In Vivo Antidiabetic Property in Streptozotocin-Nicotinamide-Induced Type 2 Diabetes in Mice | Azadirachta indica | Meliacinolin | Orally by gastric intubations | 20 mg/kg | 28 days of treatment |
[36] Novel Terpenoid-Type Quinones Isolated from Pycnanthus angolensis of Potential Utility in the Treatment of Type 2 Diabetes | Pycnanthus angolensis | Novel terpenoid-type quinones (SP-18904 and SP-18905) | Gavage | 100 mg/kg | 4 days of treatment |
[37] Platyconic Acid, a Saponin from Platycodi radix, Improves Glucose Homeostasis by Enhancing Insulin Sensitivity In Vitro and In Vivo | Platycodi radix | Platyconic acid (PA), platycodin D (PD), platycoside E (PE), and saponin with low activity (DPE) | Gavage | 20 mg/kg | 8 weeks of treatment |
[38] Rhaponticin from rhubarb Rhizomes Alleviates Liver Steatosis and Improves Blood Glucose and Lipid Profiles in KK/Ay Diabetic Mice | Rheum franzenbachii Munt | Rhaponticin | Orally | 125 mg/kg | 4 weeks of treatment |
[39] Rutin Potentiates Insulin Receptor Kinase to Enhance Insulin-Dependent Glucose Transporter 4 Translocation | Toona sinensis | Flavonoid rutin | Gavage | 25 mg/kg | ? |
[40] Type 2 Antidiabetic Activity of Bergenin from the Roots of Caesalpinia digyna Rottler | Caesalpinia digyna Rottler | Bergenin | Orally | 2.5, 5, and 10 mg/kg | 14 days of treatment |
|
Fractions | [41] A Study on Hypoglycaemic Health Care Function of Stigma maydis Polysaccharides | Stigma maydis | Stigma maydis polysaccharides | ? | 20 mg/kg | 4 weeks of treatment |
[1] Antidiabetic Activities of Extract from Malva verticillata Seed via the Activation of AMP-Activated Protein Kinase | Malva verticillata | Ethanol extract of M. verticillata and N-hexane (MVE-H) | Orally | 3 different concentrations of MVE-H (10, 20, or 40 mg/kg) | 4 weeks of treatment |
[42] Antidiabetic Activity of Alkaloids of Aerva lanata Roots on Streptozotocin-Nicotinamide Induced Type-II Diabetes in Rats | Aerva lanata Linn. | The partially purified alkaloid basified toluene fraction (PPABTF) | Orally | 10, 20 mg/kg | 2 weeks of treatment |
[43] Antidiabetic Activity of Pterospermum acerifolium Flowers and Glucose Uptake Potential of Bioactive Fraction in L6 Muscle Cell Lines with Its HPLC Fingerprint | Pterospermum acerifolium | Ethyl acetate fraction (PAFEF) and subfractions PAFE1, PAFE2, and e PAFE3 | Intragastric tube | 200, 400 mg/kg, and 15, 30 mg/kg | 30 days of treatment |
[44] Antidiabetic Activity of Caesalpinia bonducella F. in Chronic Type 2 Diabetic Model in Long-Evans Rats and Evaluation of Insulin Secretagogue Property of Its Fractions on Isolated Islets | Caesalpinia bonducella F. | Caesalpinia bonducella aqueous and alcoholic extracts (BM-170 and BM-171) | Orally | 250 mg/kg | 28 days of treatment |
[45] Antidiabetic Effect of an Acidic Polysaccharide (TAP) from Tremella aurantia and Its Degradation Product (TAP-H) | Tremella aurantia | Acidic polysaccharide (TAP) and the degradation product (TAP-H) | Orally | 0.5 g/L, 1.5 g/L | 10 weeks of treatment |
[46] Antidiabetic Effect of Orally Administered Conophylline-Containing Plant Extract on Streptozotocin-Treated and Goto-Kakizaki Rats | Tabernaemontana divaricata | The Crude Conophylline Preparation I (CCP-I) | Orally | 200, 50 g/kg | 15 days of treatment |
[47] Antidiabetic Effect of Total Flavonoids from Sanguis draxonis in Type 2 Diabetic Rats | Dracaena cochinchinensis | Sanguis draxonis (SD) and total flavonoids from SD (SDF) | Gavage | ? | 21 days of treatment |
[48] Antidiabetic Effects of Bitter Gourd Extracts in Insulin-Resistant db/db Mice | Momordica charantia | The lipid fraction, the saponin fraction, or the hydrophilic residue of bitter gourd | Orally | 150 mg/kg | 5 weeks of treatment |
[49] Anti-Diabetic Effects of Centratherum anthelminticum Seeds Methanolic Fraction on Pancreatic Cells, Β-TC6 and Its Alleviating Role in Type 2 Diabetic Rats | Centratherum anthelminticum | Crude methanolic fraction (CAMF) | Injected intraperitoneally (IP) or orally | 50 and 100 mg/kg | 4 weeks of treatment |
[17] Anti-Diabetic Effects of Polysaccharides from Talinum triangulare in Streptozotocin (STZ)-Induced Type 2 Diabetic Male Mice | Talinum triangulare | Polysaccharides obtained from Talinum triangulare (TTP) | Orally | 150 and 300 mg/kg | 2 weeks of treatment |
[50] Anti-Diabetic Effects of the Acetone Fraction of Senna singueana Stem Bark in a Type 2 Diabetes Rat Model | Senna singueana | Senna singueana acetone fraction (SSAF) | Orally | 150 mg/kg and 300 mg/kg | 4 weeks of treatment |
[51] Antidiabetic Potential of Polysaccharides from the White Oyster Culinary-Medicinal Mushroom Pleurotus florida (Higher Basidiomycetes) | Pleurotus florida | P. florida polysaccharides (PFPs) | Orally | 200 and 400 mg/kg | 21 days of treatment |
[52] Antihyperglycemic Effects of Total Flavonoids from Polygonatum odoratum in STZ and Alloxan-Induced Diabetic Rats | Polygonatum odoratum | Total flavonoids of Polygonatum (P) odoratum (TFP) | Orally | 50, 100, and 200 mg/kg | 30 days of treatment |
[53] Antioxidant and Anti-Inflammatory Effects of a Hypoglycemic Fraction from Cucurbita ficifolia Bouché in Streptozotocin-Induced Diabetic Mice | Cucurbita ficifolia | Aqueous-precipitate fraction (AP-fraction) | Gavage | 200 mg/kg | 15 days of treatment |
[54] Effect of Lycium barbarum Polysaccharide on the Improvement of Insulin Resistance in NIDDM Rats | Lycium barbarum | Lycium barbarum polysaccharide (LBP) | Orally | 10 mg/kg | 3 weeks of treatment |
[55] Effects of Grape Seed Extract and Its Ethylacetate/Ethanol Fraction on Blood Glucose Levels in a Model of Type 2 Diabetes | Vitis vinifera grape | Grape seed extract (GSE), ethylacetate (e), and ethylacetate/ethanol (ee) | Orally | 50 and 30 mg/kg | 8 weeks of treatment |
[56] Hypoglycemic Effect of Astragaluspolysaccharide and Its Effect on PTP1B1 | Astragalus membranaceus | Astragalus polysaccharide (APS) | Orally | 400 mg/kg | 5 weeks of treatment |
[57] Hypoglycemic Effects of MDG-1, a Polysaccharide Derived from Ophiopogon japonicus, in the ob/ob Mouse Model of Type 2 Diabetes Mellitus | Ophiopogon japonicus | Water-soluble β-d-fructan (MDG-1) | Intragastrically | 150 and 300 mg/kg | 23 days of treatment |
[58] Isolation and Pharmacological Activities of the Tecoma stans Alkaloids | Tecoma stans | Tecoma stans alkaloids | Gavage | 50 mg/kg and 63.4 mg/kg | 7 days of treatment |
[61] Potent Effects of the Total Saponins from Dioscorea nipponica Makino against Streptozotocin-Induced Type 2 Diabetes Mellitus in Rats | Dioscorea nipponica | Saponins from D. nipponica Makino (TSDN) | Orally | 200, 100, and 50 mg/kg | 12 weeks of treatment |
[59] Tocopherol from Seeds of Cucurbita pepo against Diabetes: Validation by In Vivo Experiments Supported by Computational Docking | Cucurbita pepo | Tocopherol | ? | 2, 5 g/kg | 6 weeks of treatment |
[60] Trapa natans L. Root Extract Suppresses Hyperglycemic and Hepatotoxic Effects in STZ-Induced Diabetic Rat Model | Trapa natans L. | Methanol fraction, chloroform fraction, and petroleum ether fraction | Orally | 50, 100, and 200 mg/kg | 15 days of treatment |
|